HopeStage
Back to all studies
RecruitingNCT02951754

Study of methylphenidate in adults with ADHD

About this titleRead the official source — NCT02951754
Medication studyAges 18+Brazil
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Porto AlegreSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateFebruary 2002
Recruitment status
Recruiting
Enrollment listed in the registry
600
Sponsor
Hospital de Clinicas de Porto Alegre
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Brazil
Age range
Over 18 Years
Official registry ID
NCT02951754
Official title
Show the full official title

Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder

Recruitment & locations

Currently recruiting

Porto Alegre

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Hospital de Clinicas de Porto Alegre, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Immediate-release Methylphenidate.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies